Log In
BCIQ
Print this Print this
 

TO-194SL

  Manage Alerts
Collapse Summary General Information
Company Japan Tobacco Inc.
DescriptionSublingual immunotherapy
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic Modality 
Latest Stage of DevelopmentRegistration
Standard IndicationAllergy
Indication DetailsTreat Japanese cedar pollinosis
Regulatory Designation Japan - Standard Review (Treat Japanese cedar pollinosis)
PartnerTorii Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today